Prospective, randomized, controlled, double-blind, multi-center, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) sOlution versus an Electrolyte solutioN In patients undergoing eleCtive abdominal Surgery: study protocol for the PHOENICS study

. 2022 Feb 22 ; 23 (1) : 168. [epub] 20220222

Jazyk angličtina Země Anglie, Velká Británie Médium electronic

Typ dokumentu protokol klinické studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid35193648
Odkazy

PubMed 35193648
PubMed Central PMC8862305
DOI 10.1186/s13063-022-06058-6
PII: 10.1186/s13063-022-06058-6
Knihovny.cz E-zdroje

BACKGROUND: Hydroxyethyl starch (HES) solutions are used for volume therapy to treat hypovolemia due to acute blood loss and to maintain hemodynamic stability. This study was requested by the European Medicines Agency (EMA) to provide more evidence on the long-term safety and efficacy of HES solutions in the perioperative setting. METHODS: PHOENICS is a randomized, controlled, double-blind, multi-center, multinational phase IV (IIIb) study with two parallel groups to investigate non-inferiority regarding the safety of a 6% HES 130 solution (Volulyte 6%, Fresenius Kabi, Germany) compared with a crystalloid solution (Ionolyte, Fresenius Kabi, Germany) for infusion in patients with acute blood loss during elective abdominal surgery. A total of 2280 eligible patients (male and female patients willing to participate, with expected blood loss ≥ 500 ml, aged > 40 and ≤ 85 years, and ASA Physical status II-III) are randomly assigned to receive either HES or crystalloid solution for the treatment of hypovolemia due to surgery-induced acute blood loss in hospitals in up to 11 European countries. The dosing of investigational products (IP) is individualized to patients' volume needs and guided by a volume algorithm. Patients are treated with IP for maximally 24 h or until the maximum daily dose of 30 ml/kg body weight is reached. The primary endpoint is the treatment group mean difference in the change from the pre-operative baseline value in cystatin-C-based estimated glomerular filtration rate (eGFR), to the eGFR value calculated from the highest cystatin-C level measured during post-operative days 1-3. Further safety and efficacy parameters include, e.g., combined mortality/major post-operative complications until day 90, renal function, coagulation, inflammation, hemodynamic variables, hospital length of stay, major post-operative complications, and 28-day, 90-day, and 1-year mortality. DISCUSSION: The study will provide important information on the long-term safety and efficacy of HES 130/0.4 when administered according to the approved European product information. The results will be relevant for volume therapy of surgical patients. TRIAL REGISTRATION: EudraCT 2016-002162-30 . ClinicalTrials.gov NCT03278548.

Anesthesiology Intensive Care Medicine and OR Facilities University and University Hospital of Zürich Zürich Switzerland

Clinic for Anesthesiology and Intensive Therapy University Clinical Center Nis School of Medicine University of Nis Nis Serbia

Clinic of Anaesthesia and Intensive Care Medicine Clinical Emergency Hospital of Bucharest Bucharest Romania

Department of Anaesthesia and Intensive Care Medicine Faculty of Medicine 'Carol Davila' University of Medicine and Pharmacy Bucharest Romania

Department of Anaesthesiology and Intensive Therapy 5th Military Clinical Hosptial Krakow Poland

Department of Anesthesia Reanimation and Pain Therapy Clinic University Hospital Valencia Spain

Department of Anesthesiology and Intensive Care Medicine Medical University of Graz Graz Austria

Department of Anesthesiology and Intensive Care Medicine Pulmonary Engineering Group University Hospital Carl Gustav Carus Technische Universität Dresden Dresden Germany

Department of Anesthesiology and Intensive Care Medicine University Hospital Schleswig Holstein Kiel Germany

Department of Anesthesiology and Intensive Care University Hospital Center Sestre Milosrdnice Zagreb Croatia

Department of Anesthesiology and Intensive Medicine University Hospital Motol Prague Czech Republic

Department of Anesthesiology and Operative Intensive Care Medicine University Hospital Bonn Bonn Germany

Department of Anesthesiology and Pain Medicine Maastricht University Medical Centre Maastricht The Netherlands

Department of Anesthesiology Intensive Care and Pain Medicine University Hospital Muenster Muenster Germany

Department of Anesthesiology University Medical Center Groningen Groningen The Netherlands

Department of Anesthesioloy and Perioperative Medicine Gent University Hospital Gent University Ghent Belgium

Department of Intensive Care and Resuscitation Anesthesiology Institute Cleveland Clinic Cleveland OH USA

Department of Medical Scientific Affairs Hospital Care Division B Braun Melsungen AG Melsungen Germany

Department of Outcomes Research Anesthesiology Institute Cleveland Clinic Cleveland OH USA

Department of Surgery Clinic University Hospital Valencia Spain

Division of Acute and Critical Medicine Maastricht University Medical Centre Maastricht The Netherlands

European Society of Anaesthesiology and Intensive Care Brussels Belgium

Fresenius Kabi Deutschland GmbH Bad Homburg Germany

Institute of Anesthesiology University and University Hospital of Zürich Zürich Switzerland

Service d'Anesthésie Réanimation Hôpital Européen Georges Pompidou Paris France

Zobrazit více v PubMed

Gutierrez G, Reines HD, Wulf-Gutierrez ME. Clinical review: hemorrhagic shock. Critical Care. 2004;8(5):373–381. doi: 10.1186/cc2851. PubMed DOI PMC

Chappell D, Westphal M, Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Current Opinion in Anaesthesiology. 2009;22(2):155–162. doi: 10.1097/ACO.0b013e328328d1b6. PubMed DOI

Chappell D, Jacob M. Flüssigkeits- und Volumentherapie 2013 Fluid and volume therapy in 2013. Notfall + Rettungsmedizin. 2013;16:617–624. doi: 10.1007/s10049-013-1805-8. DOI

Heringlake M, Heinze H, Brauer K. Perioperatives Flüssigkeitsmanagement - Welches Volumen für welchen Patienten? Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie. 2012;47(07/08):482–489. doi: 10.1055/s-0032-1323570. PubMed DOI

Yates DRA, Davies SJ, Milner HE, Wilson RJT. Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery. British Journal of Anaesthesia. 2014;112(2):281–289. doi: 10.1093/bja/aet307. PubMed DOI

Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology. 2013;118:387–394. doi: 10.1097/ALN.0b013e31827e5569. PubMed DOI

Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Critical Care Medicine. 2011;39(2):259–265. doi: 10.1097/CCM.0b013e3181feeb15. PubMed DOI

Sadaka F, Juarez M, Naydenov S, O’Brien J. Fluid resuscitation in septic shock: the effect of increasing fluid balance on mortality. J Intens Care Med. 2014;29(4):213–217. doi: 10.1177/0885066613478899. PubMed DOI

Payen D, de Pont AC, Sakr Y, Spies C, Reinhart K, Vincent JL. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care. 2008;12(3):R74. doi: 10.1186/cc6916. PubMed DOI PMC

Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL, Program to Improve Care in Acute Renal Disease (PICARD) Study Group Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney International. 2009;76(4):422–427. doi: 10.1038/ki.2009.159. PubMed DOI

Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesthesia and Analgesia. 2013;116(1):35–48. doi: 10.1213/ANE.0b013e31827175da. PubMed DOI

Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J, 6S Trial Group. Scandinavian Critical Care Trials Group Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. New England Journal of Medicine. 2012;367(2):124–134. doi: 10.1056/NEJMoa1204242. PubMed DOI

Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SAR. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine. 2012;367(20):1901–1911. doi: 10.1056/NEJMoa1209759. PubMed DOI

Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine. 2008;358(2):125–139. doi: 10.1056/NEJMoa070716. PubMed DOI

Futier E, Garot M, Godet T, Biais M, Verzilli D, Ouattara A, Huet O, Lescot T, Lebuffe G, Dewitte A, Cadic A, Restoux A, Asehnoune K, Paugam-Burtz C, Cuvillon P, Faucher M, Vaisse C, el Amine Y, Beloeil H, Leone M, Noll E, Piriou V, Lasocki S, Bazin JE, Pereira B, Jaber S, for the FLASH Trial Group Effect of hydroxyethyl starch vs saline for volume replacement therapy on death or postoperative complications among high-risk patients undergoing major abdominal surgery: the FLASH Randomized Clinical Trial. JAMA. 2020;323(3):1346–1357. doi: 10.1001/jama.2019.20833. PubMed DOI PMC

Kabon B, Sessler DI, Kurz A, Maheshwari K, Babazade R, Fiffick A, et al. Effect of intraoperative goal-directed balanced crystalloid versus colloid administration on major postoperative morbidity: a randomized trial. Anesthesiology. 2019;130(5):728–744. doi: 10.1097/ALN.0000000000002601. PubMed DOI

Joosten A, Delaporte A, Ickx B, Touihri K, Stany I, Barvais L, van Obbergh L, Loi P, Rinehart J, Cannesson M, van der Linden P. Crystalloid versus colloid for intraoperative goal-directed fluid therapy using a closed-loop system: a randomized, double-blinded, controlled trial in major abdominal surgery. Anesthesiology. 2018;128(1):55–66. doi: 10.1097/ALN.0000000000001936. PubMed DOI

Turrentine FE, Wang H, Simpson VB, Jones RS. Surgical risk factors, morbidity, and mortality in elderly patients. Journal of the American College of Surgeons. 2006;203(6):865–877. doi: 10.1016/j.jamcollsurg.2006.08.026. PubMed DOI

Story DA, Leslie K, Myles PS, Fink M, Poustie SJ, Forbes A, Yap S, Beavis V, Kerridge R, on behalf of the REASON Investigators, Australian and New Zealand College of Anaesthetists Trials Group Complications and mortality in older surgical patients in Australia and New Zealand (the REASON study): a multicentre, prospective, observational study. Anaesthesia. 2010;65(10):1022–1030. doi: 10.1111/j.1365-2044.2010.06478.x. PubMed DOI

Kozek-Langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, de Robertis E, Faraoni D, Filipescu DC, Fries D, Haas T, Jacob M, Lancé MD, Pitarch JVL, Mallett S, Meier J, Molnar ZL, Rahe-Meyer N, Samama CM, Stensballe J, van der Linden PJF, Wikkelsø AJ, Wouters P, Wyffels P, Zacharowski K. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2017;34(6):270–382. doi: 10.1097/EJA.0000000000000630. PubMed DOI

Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, van Lente F, Zhang YL, Coresh J, Levey AS, CKD-EPI Investigators Estimating glomerular filtration rate from serum creatinine and cystatin C. New England Journal of Medicine. 2012;367(1):20–29. doi: 10.1056/NEJMoa1114248. PubMed DOI PMC

Felicio ML, de Andrade RR, Castiglia YMM, Silva MA de M, Vianna PTG, Martins AS. Cystatin C and glomerular filtration rate in the cardiac surgery with cardiopulmonary bypass. Brazilian J Cardiovasc Surg. 2009;24(3):305–311. doi: 10.1590/S0102-76382009000400008. PubMed DOI

European Medicines Agency. ICH Topic E 9 Statistical Principles for Clinical Trials. London; 1998.

Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204–R212. doi: 10.1186/cc2872. PubMed DOI PMC

De Hert S, De Baerdemaeker L. Why hydroxyethyl starch solutions should not be banned from the operating room. Anaesthesiology Intensive Therapy. 2014;46(5):336–341. doi: 10.5603/AIT.2014.0057. PubMed DOI

Marx G, Schindler AW, Mosch C, Albers J, Bauer M, Gnass I, Hobohm C, Janssens U, Kluge S, Kranke P, Maurer T, Merz W, Neugebauer E, Quintel M, Senninger N, Trampisch HJ, Waydhas C, Wildenauer R, Zacharowski K, Eikermann M. Intravascular volume therapy in adults. European Journal of Anaesthesiology. 2016;33(7):488–521. doi: 10.1097/EJA.0000000000000447. PubMed DOI PMC

Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, Grocott MP, Ahern A, Griggs K, Scott R, Hinds C, Rowan K, OPTIMISE Study Group Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery a randomized clinical trial and systematic review. JAMA. 2014;311(21):2181–2190. doi: 10.1001/jama.2014.5305. PubMed DOI

Van Kuijk JP, Flu WJ, Chonchol M, Hoeks SE, Winkel TA, Verhagen HJM, et al. Temporary perioperative decline of renal function is an independent predictor for chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(7):1198–1204. doi: 10.2215/CJN.00020110. PubMed DOI PMC

Welten GM, Schouten O, Chonchol M. Temporary worsening of renal function after aortic surgery is associated with higher long-term mortality. J Vasc Surg. 2008;47(2):219–228. doi: 10.1016/j.jvs.2007.12.016. PubMed DOI

Boyd O, Jackson N. Clinical review: how is risk defined in high-risk surgical patient management? Crit Care. 2005;9(4):390–396. doi: 10.1186/cc3057. PubMed DOI PMC

Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesthesia and Analgesia. 2011;112(6):1392–1402. doi: 10.1213/ANE.0b013e3181eeaae5. PubMed DOI

Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242(3):326–341. doi: 10.1097/01.sla.0000179621.33268.83. PubMed DOI PMC

Head J, Ferrie JE, Alexanderson K, Westerlund H, Vahtera J, Kivimäki M. Diagnosis-specific sickness absence as a predictor of mortality: the Whitehall II prospective cohort study. BMJ. 2008;337(oct02 2):a1469. doi: 10.1136/bmj.a1469. PubMed DOI PMC

Calvert S, Shaw A. Perioperative acute kidney injury. Perioperative Medicine. 2012;1(1):6. doi: 10.1186/2047-0525-1-6. PubMed DOI PMC

Kheterpal S, Tremper KK, Englesbe MJ, O’Reilly M, Shanks AM, Fetterman DM, Rosenberg AL, Swartz RD. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology. 2007;107(6):892–902. doi: 10.1097/01.anes.0000290588.29668.38. PubMed DOI

Silva JM, De Oliveira AMRR, Nogueira FAM, Vianna PMM, Pereira Filho MC, Dias LF, et al. The effect of excess fluid balance on the mortality rate of surgical patients: a multicenter prospective study. Crit Care. 2013;17(6):R288. doi: 10.1186/cc13151. PubMed DOI PMC

Pearse RM, Harrison DA, James P, Watson D, Hinds C, Rhodes A, Grounds RM, Bennett ED. Identification and characterisation of the high-risk surgical population in the United Kingdom. Critical Care. 2006;10(3):R81. doi: 10.1186/cc4928. PubMed DOI PMC

Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, Vallet B, Vincent JL, Hoeft A, Rhodes A, European Surgical Outcomes Study (EuSOS) group for the Trials groups of the European Society of Intensive Care Medicine and the European Society of Anaesthesiology Mortality after surgery in Europe: a 7 day cohort study. The Lancet. 2012;380(9847):1059–1065. doi: 10.1016/S0140-6736(12)61148-9. PubMed DOI PMC

O’Connor ME, Kirwan CJ, Pearse RM, Prowle JR. Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Medicine. 2016;42(4):521–530. doi: 10.1007/s00134-015-4157-7. PubMed DOI

Sear JW. Kidney dysfunction in the postoperative period. British Journal of Anaesthesia. 2005;95(1):20–32. doi: 10.1093/bja/aei018. PubMed DOI

Zobrazit více v PubMed

ClinicalTrials.gov
NCT03278548

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...